A Phase II Trial Assessing the Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 12 Jan 2010
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Cancer metastases; Colorectal cancer
- Focus Therapeutic Use
- 12 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jan 2010 Actual patient number (172) added as reported by ClinicalTrials.gov.
- 26 Nov 2005 New trial record.